What is a Control Group? Definition, How to Choose, Uses

Getting your Trinity Audio player ready...

Contents

• What Is a Control Group?
• Key Terms to Know
• Why Are Control Groups Important?
• Types of Control Groups
• Control Groups in Experimental vs. Non-Experimental Research
• How to Design an Effective Control Group
• Common Challenges and How to Address Them
• Risks of an Invalid Control Group
• Control Groups Beyond the Laboratory
• Positive vs. Negative Controls at a Glance
• Key Takeaways
• Frequently Asked Questions

In science, arriving at a trustworthy conclusion is rarely as simple as running an experiment and observing what happens. Without a proper point of comparison, results can be misleading, and false conclusions can slip through even the most carefully designed studies. This is where the control group comes in, one of the most fundamental concepts in experimental research.

What Is a Control Group?

A control group is the standard to which comparisons are made in an experiment. Ideally, the control group and the experimental groups are identical in every way except that the experimental groups are subjected to treatments or interventions believed to have an effect on the outcome of interest, while the control group is not.

In practice, researchers change the independent variable in the treatment group and keep it constant in the control group, then compare the results of these groups.  

Put simply: the control group is the status quo. Researchers compare the effects in the experimental group against the control group. The independent variable is the thing the researchers are testing: they are trying to determine whether it’s responsible for any change that occurs in the experiment.

Key Terms to Know

Term	Definition
Control group	The group that does not receive the experimental treatment; the baseline for comparison
Experimental (treatment) group	The group that receives the intervention being tested
Independent variable	The factor being deliberately changed or manipulated
Dependent variable	The outcome being measured to assess the effect of the independent variable
Confounding variable	A third variable related to both the cause and the effect that could distort results
Placebo	An inert substance or fake treatment given to the control group to account for psychological effects

Why Are Control Groups Important?

Inclusion of a control group greatly strengthens researchers’ ability to draw conclusions from a study. Only in the presence of a control group can a researcher determine whether a treatment under investigation truly has a significant effect on an experimental group, and the possibility of making an erroneous conclusion is reduced.  

Control groups are an essential component of all experiments, both in vitro and in vivo, and fulfil a number of important roles in any experimental design. Perhaps most importantly they help you understand the influence of variables that you cannot fully eliminate from your experiment and thus include them in your analysis of treatment effects.  

Core benefits of including a control group:

• Establishes causality: confirms that observed changes are due to the treatment, not other factors
• Validates results: provides a standard against which treatment effects are evaluated
• Minimizes bias: controls for extraneous variables and confounders
• Accounts for the placebo effect: separates psychological expectation from real therapeutic effect
• Improves internal validity: strengthens the overall rigor of the research design
• Informs decision-making: in both clinical and business contexts, enables data-driven conclusions

For example, people often recover from illnesses or injuries over time regardless of whether they’ve received effective treatment or not. Thus, without a control group, it’s difficult to determine whether improvements in medical conditions come from a treatment or just the natural progression of time.  

Example

In a pharmaceutical study to determine the effectiveness of a new drug on the treatment of migraines, the experimental group will be administered the new drug and the control group will be administered a placebo (a drug that is inert, or assumed to have no effect). Each group is then given the same questionnaire and asked to rate the effectiveness of the drug in relieving symptoms. If the new drug is effective, the experimental group is expected to have a significantly better response to it than the control group.  

Another possible design: include several experimental groups, each of which is given a different dosage of the new drug, plus one control group. This type of experiment allows the researcher to determine not only if the drug is effective but also the effectiveness of different dosages.  

Group	Treatment	Purpose
Control group	Placebo (sugar pill)	Baseline; accounts for placebo effect
Experimental group A	Low dose of new drug	Tests dose-response at low level
Experimental group B	High dose of new drug	Tests dose-response at high level

Types of Control Groups

Each type of control group has its own advantages and limitations, and the choice of which to use depends on various factors including the research question, ethical considerations, and practical constraints.

Placebo Control Group

A placebo control group is a standard against which the effects of a treatment are compared. Participants in this group receive a placebo: an inactive substance or treatment that resembles the active treatment but has no therapeutic effect. Placebo control groups are instrumental in clinical trials for evaluating the efficacy of new medications or interventions.  

Example:

In a clinical trial for a new antibiotic, the control group receives an identical-looking capsule containing no active compound, while the experimental group receives the antibiotic. This isolates the drug’s true antibacterial effect from the patient’s expectation of recovery.

Active Control Group

Unlike a placebo control group, an active control group receives an established treatment or intervention rather than a placebo. The purpose of an active control group is to compare the effects of the experimental treatment against those of an existing standard of care or alternative intervention.

Why use an active control group?

Active control groups help establish whether the experimental treatment is superior, inferior, or equivalent to the active comparator. This design is advantageous when ethical considerations preclude the use of a placebo or when there is an established standard of care for the condition being studied.  

Example:

In a clinical trial for a new antidepressant, the control group receives a proven first-line antidepressant rather than a placebo, since denying treatment to a depressed patient would be unethical. The trial then compares the efficacy and tolerability profiles of the two drugs.

Negative Control Group

The independent variable does not change in a negative control group. This group represents the true status quo, and you would test the experimental group against it.  

Example:

In a cell culture experiment testing whether a growth factor promotes tumor cell proliferation, the negative control group receives plain culture medium with no added growth factor. Any increase in proliferation in the treated group can then be attributed to the growth factor.

Positive Control Group

In positive control groups, the independent variable is changed where it is already known to have an effect. You would compare this group’s results against those from the experimental group receiving a variation of the same independent variable. This would enable you to determine if the effect changes.  

Example:

In a drug screening assay, the positive control group receives a compound already known to inhibit a specific enzyme. If the positive control does not produce the expected inhibition, it signals that something is wrong with the experimental setup itself, not the new drug.

Historical Control Group

A historical control group consists of data or outcomes from previous studies or existing databases that serve as a comparison for the current study. Rather than recruiting new participants, researchers use historical data to assess the effectiveness of a treatment or intervention. Historical control groups are useful when it is impractical, unethical, or cost-prohibitive to conduct a new study with a control group.  

Example:

Researchers developing a treatment for a rare genetic disease might compare patient outcomes to historical registry data from untreated patients diagnosed decades earlier, since enrolling a concurrent placebo group may be ethically indefensible given the severity of the condition.

No-Treatment Control Group

In a no-treatment control group, participants do not receive any form of treatment or intervention. This type of control group is beneficial for assessing the natural progression of a condition or disease over time. The primary purpose is to determine whether any observed changes in the treatment group are attributable to the intervention itself rather than to spontaneous recovery, regression to the mean, or other external factors.  

Summary of Control Group Types

Type	What the Control Group Receives	When It’s Used
Placebo control	Inert substance mimicking the treatment	Standard drug/therapy trials where no established treatment exists
Active control	An existing, proven treatment	When withholding all treatment is unethical
Negative control	No intervention at all	Basic experiments; establishes true baseline
Positive control	A known-effective intervention	Validates experimental conditions and assay performance
Historical control	No concurrent group; uses past data	Rare diseases; feasibility constraints

Control Groups in Experimental vs. Non-Experimental Research

Experimental Research

Control groups are essential to experimental design. When researchers are interested in the impact of a new treatment, they randomly divide their study participants into at least two groups: the treatment group (also called the experimental group) receives the treatment whose effect the researcher is interested in, and the control group receives either no treatment, a standard treatment whose effect is already known, or a placebo.  

In a well-designed experiment, all variables apart from the treatment should be kept constant between the two groups. This means researchers can correctly measure the entire effect of the treatment without interference from confounding variables.  

Non-Experimental Research

Although control groups are more common in experimental research, they can be used in other types of research too. Researchers generally rely on non-experimental control groups in two cases: quasi-experimental or matching design.  

Quasi-experimental design:

While true experiments rely on random assignment to the treatment or control groups, quasi-experimental design uses some criterion other than randomization to assign people. Often, these assignments are not controlled by researchers, but are pre-existing groups that have received different treatments.  

Example:

A hospital implements a new hand hygiene protocol in one ward but not another. Researchers then compare infection rates across wards: the ward without the new protocol serves as the quasi-experimental control group.

Matching design:

In matching designs, the researcher matches individuals who received the “treatment” to others who did not: the control group. Each member of the treatment group thus has a counterpart in the control group identical in every way possible outside of the treatment.  

Example:

A researcher studying the long-term effects of occupational asbestos exposure on lung function matches each exposed worker (by age, sex, smoking history, and BMI) to an unexposed worker in the same factory. This minimizes the influence of lifestyle confounders.

How to Design an Effective Control Group

Step 1: Identify Your Variables

• Independent variable: What are you manipulating? (e.g., drug dose, surgical technique)
• Dependent variable: What outcome are you measuring? (e.g., tumor size, blood glucose, survival time)
• Confounding variables: What else could affect the outcome? (e.g., age, comorbidities, diet)

Step 2: Choose a Randomization Technique

Randomization is a critical aspect of control group design that helps minimize bias and ensure the comparability of treatment and control groups.  

• Simple randomization: participants are randomly assigned to groups with no stratification
• Stratified randomization: participants are divided into subgroups (e.g., by disease severity or sex) and then randomized within each subgroup
• Blocked randomization: grouping participants into blocks of equal size ensures balance even with small sample sizes

Step 3: Determine Sample Size

Conduct a power analysis to determine the minimum sample size required to detect a meaningful effect size with adequate statistical power. Consider factors such as the desired level of significance, effect size, and expected variability in the outcome measure. Anticipate dropouts and account for them when calculating the required number of participants.  

Step 4: Apply Blinding

A control group study can be managed through blinding in two different ways. In a single-blind study, the researcher will know whether a particular subject is in the control group, but the subject will not know. In a double-blind study, neither the subject nor the researcher will know which treatment the subject is receiving.

In many cases, a double-blind study is preferable to a single-blind study, since the researcher cannot inadvertently affect the results or their interpretation by treating a control subject differently from an experimental subject.  

Step 5: Keep Conditions Identical

It is important that every aspect of the experimental environment be as alike as possible for all subjects in the experiment. If conditions are different for the experimental and control groups, it is impossible to know whether differences between groups are actually due to the difference in treatments or to the difference in environment.  

Example of poor design:

Administering a questionnaire to the drug-treated migraine group in a hospital setting while asking the placebo group to complete it at home. Responses could reflect the different environments rather than the drug’s effect.

Common Challenges and How to Address Them

Challenge	Description	Solution
Recruitment difficulties	Stringent eligibility criteria limit participant numbers	Broaden inclusion criteria; use community partnerships; offer incentives
Ethical dilemmas	Denying treatment to a control group may be unethical	Use active controls; seek ethics board guidance
Sample size limitations	Rare diseases or resource constraints reduce statistical power	Power analysis before starting; collaborate with other research sites
Confounding variables	Unmeasured factors distort results	Randomization; matching; statistical adjustment (e.g., ANCOVA)
Loss to follow-up	Attrition undermines group comparability	Proactive retention strategies; intent-to-treat analysis
Measurement bias	Assessors unconsciously score groups differently	Double-blinding; standardized protocols; validated instruments
Publication bias	Negative results go unpublished, skewing the literature	Pre-registration of trials; submit results regardless of significance

Risks of an Invalid Control Group

If your control group differs from the treatment group in ways that you haven’t accounted for, your results may reflect the interference of confounding variables instead of your independent variable.  

Example:

A researcher studying whether e-cigarette use causes lung cancer compares cancer rates between smokers and non-smokers but forgets to control for family history of smoking. Participants from smoking households are more likely to be exposed to secondhand smoke: a known carcinogen: making it impossible to tell whether the cancer risk is from e-cigarettes or secondhand smoke exposure.

Minimizing This Risk

• Account for all potential confounding variables, ideally through experimental rather than observational design
• Use double-blinding to prevent unconscious behavioral differences between groups
• Randomly assign your subjects into control and treatment groups. This method will allow you to not only minimize the differences between the two groups on confounding variables that you can directly observe, but also those you cannot.  

Control Groups Beyond the Laboratory

Control groups are not exclusive to clinical or laboratory research. They are equally powerful in other domains:

Market Research

In marketing experiments, control groups are used to evaluate the impact of marketing campaigns, promotions, or product launches. The company can measure the campaign’s effectiveness in driving sales by comparing sales data between the two groups over a specific period. This helps businesses make data-driven decisions about marketing strategies and resource allocation.  

Product Testing

In a study evaluating the efficacy of a new skincare product in reducing wrinkles, participants may be assigned to either the treatment group, which applies the new product, or the control group, which uses a placebo or standard skincare product. By comparing changes in wrinkle depth or skin texture between the two groups, researchers can determine the product’s effectiveness in achieving its intended purpose.  

Policy Research

A government introduces a nutritional supplement program in selected schools and leaves others unchanged. By comparing health outcomes and academic performance between participating and non-participating schools over a school year, policymakers can evaluate the program’s real-world impact.

Positive vs. Negative Controls at a Glance

Feature	Negative Control	Positive Control
Independent variable	Unchanged (no intervention)	Changed to a known-effective condition
Purpose	Establishes the true baseline	Validates that the experiment is working correctly
Result if working correctly	No effect observed	Known effect observed
Biomedical example	Untreated cell culture	Cell culture treated with a proven growth inhibitor

Key Takeaways

• A control group is the comparison standard in any experiment: it receives no treatment, a placebo, or an established treatment, while everything else is held constant.
• Control groups fulfil a number of important roles in any experimental design and help you understand the influence of variables that you cannot fully eliminate from your experiment.  
• There are several types: placebo, active, negative, positive, historical, and no-treatment. Each is suited to different research questions and ethical contexts.
• Proper randomization, blinding, sample size calculation, and environmental consistency are essential to the validity of a control group.
• In almost all cases, contemporaneous control groups are required. Historical and baseline control groups serve a slightly different role and cannot fully replace control groups run as an integral part of the experiment. When used correctly, a good control group not only validates your experiment but also provides the basis for evaluating the effect of your treatments.

Frequently Asked Questions

Can a participant serve as their own control group?

Yes, this is called a within-subjects design (or crossover design). Instead of splitting participants into separate groups, each participant goes through both the control and treatment conditions at different time points.

Example

In pharmacology, for example, a patient might receive a placebo for four weeks, then the experimental drug for four weeks, with a washout period in between to eliminate carryover effects.

This approach is powerful because it eliminates between-person variability entirely. However, it is not always feasible. If the treatment produces a permanent change (such as a surgical procedure or a vaccine), you cannot “undo” it to test the control condition afterward.

How long should a control group be observed?

The observation period must be long enough to capture the full effect of the intervention, including any delayed responses. In a short-acting analgesic trial, a few hours of observation may suffice. In oncology trials testing a new chemotherapy agent, follow-up may span years to assess survival outcomes and late-onset toxicities. A common mistake is ending observation too early: a drug may appear ineffective at four weeks but show significant benefit at twelve.

The duration should always be determined during the study design phase, based on the known biological timeline of the condition being studied, not adjusted after data collection begins, as that introduces bias.

What is the difference between a control group and a control variable?

A control group is a set of participants who do not receive the experimental treatment whereas a control variable (also called a controlled variable) is any factor that is deliberately held constant across all groups (both control and experimental) to prevent it from influencing the results.

Example

In a blood pressure drug trial, the control group receives a placebo, while control variables might include the time of day medication is administered, the dietary instructions given to all participants, and how blood pressure is measured. Both concepts are essential, but they operate at different levels of the experiment.

Are control groups required for regulatory drug approval?

In most jurisdictions, yes, at least for pivotal efficacy trials. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) generally require evidence from randomized controlled trials with clearly defined control conditions before approving a new drug.

The choice of comparator matters too: regulators increasingly prefer active-controlled trials over placebo-only designs for conditions where effective treatments already exist, on both ethical and scientific grounds.

For certain rare diseases or life-threatening conditions with no existing treatment, the bar may be adjusted, and historical control data may be accepted, but this remains the exception and is subject to rigorous scrutiny.

Can the control group ever accidentally receive the treatment?

Yes, and this is called contamination and is one of the more insidious threats to a trial’s validity. It occurs when participants in the control group are inadvertently exposed to the experimental intervention.

Example

In a hospital-based infection control study, for instance, if nursing staff trained in a new hand hygiene protocol naturally apply the same techniques when treating control-ward patients, the control condition is no longer truly “untreated.”

Contamination dilutes the observed difference between groups and can lead researchers to underestimate the treatment’s true effect. Strategies to prevent it include

• geographic separation of groups,
• clear staff allocation protocols, and
• monitoring compliance throughout the study.

How do ethical review boards evaluate the use of control groups?

Institutional Review Boards (IRBs) and Ethics Committees assess whether assigning participants to a control condition is justifiable. The central ethical test is clinical equipoise: genuine uncertainty in the expert community about which treatment is superior.

If strong evidence already exists that a treatment works, assigning patients to a placebo control may be considered unethical because it withholds a known benefit. Boards also evaluate informed consent procedures, ensuring that participants understand they may be in a control group, the risks of receiving no active treatment, and their right to withdraw at any time. In paediatric trials or studies in vulnerable populations, this scrutiny is heightened considerably.